Proton Therapy in the Management of Pancreatic Cancer

Abstract

Radiation therapy plays a central role in the treatment of pancreatic cancer. While gener-ally shown to be feasible, proton irradiation, particularly when an ablative dose is planned, remains a challenge, especially due to tumor motion and the proximity to organs at risk, like the stomach, duodenum, and bowel. Clinically, standard doses of proton radiation treatment have not been shown to be statistically different from photon radiation treatment in terms of oncologic outcomes and toxicity rates as per non-randomized comparative studies. Fractionation schedules and concurrent chemotherapy combinations are yet to be optimized for proton therapy and are the subject of ongoing trials. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.